5:19 PM
 | 
Dec 16, 2011
 |  BC Extra  |  Company News

EC approves Ameluz for actinic keratosis

The European Commission approved Ameluz ( BF-200 ALA) from Biofrontera AG (Xetra:B8F) to...

Read the full 57 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >